Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome

Diabetology and Metabolic Syndrome

Volumn 5, Issue 1, 2013, Pages

  Turcot, Valérie ^a,b,c   Tchernof, André ^b,c   Deshaies, Yves ^c,d   Pérusse, Louis ^a,c   Bélisle, Alexandre ^e   Marceau, Picard ^c,d   Hould, Frédéric Simon ^c,d   Lebel, Stéfane ^c,d   Vohl, Marie Claude ^a,b,c  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

DNA methylation; DPP4 gene; Epigenetics; Plasma cholesterol; Visceral adipose tissue; White blood cells

Indexed keywords

BISULFITE; CHOLESTEROL; DIPEPTIDYL PEPTIDASE IV; DNA; LIPID;

ADULT; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CPG ISLAND; DNA EXTRACTION; DNA METHYLATION; EXON; FEMALE; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAABDOMINAL FAT; LEUKOCYTE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PYROSEQUENCING;

EID: 84876917790     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-5-4     Document Type: Article

References (36)

1. Obesity, inflammation, and cardiovascular risk. Mathieu P, Lemieux I, Despres JPMathieu P, Lemieux I, Despres JP, Clin Pharmacol Ther 2010 87 407 416 10.1038/clpt.2009.311 20200516
2. Genetics of the metabolic syndrome. Teran-Garcia M, Bouchard CTeran-Garcia M, Bouchard C, Appl Physiol Nutr Metab 2007 32 89 114 10.1139/h06-102 17332787
3. ZFP36: a promising candidate gene for obesity-related metabolic complications identified by converging genomics. Bouchard L, Tchernof A, Deshaies Y, Marceau S, Lescelleur O, Biron S, Vohl MCBouchard L, Tchernof A, Deshaies Y, Marceau S, Lescelleur O, Biron S, Vohl MC, Obes Surg 2007 17 372 382 10.1007/s11695-007-9067-5 17546847 (Pubitemid 46659299)
4. Comprehensive genetic analysis of the dipeptidyl peptidase-4 gene and cardiovascular disease risk factors in obese individuals. Bouchard L, Faucher G, Tchernof A, Deshaies Y, Lebel S, Hould FS, Marceau P, Vohl MCBouchard L, Faucher G, Tchernof A, Deshaies Y, Lebel S, Hould FS, Marceau P, Vohl MC, Acta Diabetol 2009 46 13 21 10.1007/s00592-008-0049-4 18682883
5. Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Abbott CA, Baker E, Sutherland GR, McCaughan GWAbbott CA, Baker E, Sutherland GR, McCaughan GW, Immunogenetics 1994 40 331 338 10.1007/BF01246674 7927537 (Pubitemid 24299322)
6. On the origin of serum CD26 and its altered concentration in cancer patients. Cordero OJ, Salgado FJ, Nogueira MCordero OJ, Salgado FJ, Nogueira M, Cancer Immunol Immunother 2009 58 1723 1747 10.1007/s00262-009-0728-1 19557413
7. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Lambeir AM, Durinx C, Scharpe S, De Meester ILambeir AM, Durinx C, Scharpe S, De Meester I, Crit Rev Clin Lab Sci 2003 40 209 294 10.1080/713609354 12892317 (Pubitemid 36775376)
8. Dipeptydil peptidase-4 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials. Monami M, Iacomelli I, Marchionni N, Mannucci EMonami M, Iacomelli I, Marchionni N, Mannucci E, Nutr Metab Cardiovasc Dis 2010 20 224 235 10.1016/j.numecd.2009.03.015 19515542
9. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, Eckardt K, Kaufman JM, Ryden M, Muller S, Hanisch FG, Ruige J, Arner P, Sell H, Eckel JLamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, Eckardt K, Kaufman JM, Ryden M, Muller S, Hanisch FG, Ruige J, Arner P, Sell H, Eckel J, Diabetes 2011 60 1917 1925 10.2337/db10-1707 21593202
10. DPP4 gene DNA methylation in the omentum is associated with its gene expression and plasma lipid profile in severe obesity. Turcot V, Bouchard L, Faucher G, Tchernof A, Deshaies Y, Perusse L, Belisle A, Marceau S, Biron S, Lescelleur O, Biertho L, Vohl MCTurcot V, Bouchard L, Faucher G, Tchernof A, Deshaies Y, Perusse L, Belisle A, Marceau S, Biron S, Lescelleur O, Biertho L, Vohl MC, Obesity (Silver Spring) 2011 19 388 395 10.1038/oby.2010.198
11. Report of the expert committee on the diagnosis and classification of diabetes mellitus. The Expert Committee on the Diagnosis and Classification of Diabetes MellitusThe Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care 2003 26 Suppl 1 5 20 12502614
12. Effects of the peroxisome proliferator-activated receptor-gamma co-activator-1 Gly482Ser variant on features of the metabolic syndrome. Vohl MC, Houde A, Lebel S, Hould FS, Marceau PVohl MC, Houde A, Lebel S, Hould FS, Marceau P, Mol Genet Metab 2005 86 300 306 10.1016/j.ymgme.2005.07.002 16122961 (Pubitemid 41412188)
13. Biliopancreatic diversion with duodenal switch. Marceau P, Hould FS, Simard S, Lebel S, Bourque RA, Potvin M, Biron SMarceau P, Hould FS, Simard S, Lebel S, Bourque RA, Potvin M, Biron S, World J Surg 1998 22 947 954 10.1007/s002689900498 9717420 (Pubitemid 28374612)
14. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Vohl MC, Sladek R, Robitaille J, Gurd S, Marceau P, Richard D, Hudson TJ, Tchernof AVohl MC, Sladek R, Robitaille J, Gurd S, Marceau P, Richard D, Hudson TJ, Tchernof A, Obes Res 2004 12 1217 1222 10.1038/oby.2004.153 15340102 (Pubitemid 41137463)
15. Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation. Alberti KG, Zimmet P, Shaw JAlberti KG, Zimmet P, Shaw J, Diabet Med 2006 23 469 480 16681555
16. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Expert Panel on Detection EaToHBCiAExpert Panel on Detection EaToHBCiA, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
17. Pyro Q-CpG: quantitative analysis of methylation in multiple CpG sites by Pyrosequencing. England R, Pettersson MEngland R, Pettersson M, Nature Methods 2005 2 10.1038
18. A polymorphism of the interferon-gamma-inducible protein 30 gene is associated with hyperglycemia in severely obese individuals. Turcot V, Bouchard L, Faucher G, Tchernof A, Deshaies Y, Perusse L, Marceau P, Hould FS, Lebel S, Vohl MCTurcot V, Bouchard L, Faucher G, Tchernof A, Deshaies Y, Perusse L, Marceau P, Hould FS, Lebel S, Vohl MC, Hum Genet 2012 131 57 66 10.1007/s00439-011-1043-4 21701784
19. Dipeptidyl peptidase IV (DPPIV), a candidate tumor suppressor gene in melanomas is silenced by promoter methylation. McGuinness C, Wesley UVMcGuinness C, Wesley UV, Front Biosci 2008 13 2435 2443 10.2741/2856 17981724 (Pubitemid 351611600)
20. Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells. Tsuji T, Sugahara K, Tsuruda K, Uemura A, Harasawa H, Hasegawa H, Hamaguchi Y, Tomonaga M, Yamada Y, Kamihira STsuji T, Sugahara K, Tsuruda K, Uemura A, Harasawa H, Hasegawa H, Hamaguchi Y, Tomonaga M, Yamada Y, Kamihira S, Int J Hematol 2004 80 254 260 10.1532/IJH97.04066 15540901 (Pubitemid 39410933)
21. Interferon-gamma induces dipeptidylpeptidase IV expression in human glomerular epithelial cells. Stefanovic V, Ardaillou N, Vlahovic P, Placier S, Ronco P, Ardaillou RStefanovic V, Ardaillou N, Vlahovic P, Placier S, Ronco P, Ardaillou R, Immunology 1993 80 465 470 7904591 (Pubitemid 23336698)
22. Induction of the 2B9 antigen/dipeptidyl peptidase IV/CD26 on human natural killer cells by IL-2, IL-12 or IL-15. Yamabe T, Takakura K, Sugie K, Kitaoka Y, Takeda S, Okubo Y, Teshigawara K, Yodoi J, Hori TYamabe T, Takakura K, Sugie K, Kitaoka Y, Takeda S, Okubo Y, Teshigawara K, Yodoi J, Hori T, Immunology 1997 91 151 158 10.1046/j.1365-2567.1997.00230.x 9203979 (Pubitemid 27196013)
23. Investigations into the actions of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1(7-36)amide on lipoprotein lipase activity in explants of rat adipose tissue. Knapper JM, Puddicombe SM, Morgan LM, Fletcher JMKnapper JM, Puddicombe SM, Morgan LM, Fletcher JM, J Nutr 1995 125 183 188 7861244
24. GIP biology and fat metabolism. Yip RG, Wolfe MMYip RG, Wolfe MM, Life Sci 2000 66 91 103 10666005 (Pubitemid 30025456)
25. Lipoprotein lipase: structure, function, regulation, and role in disease. Mead JR, Irvine SA, Ramji DPMead JR, Irvine SA, Ramji DP, J Mol Med (Berl) 2002 80 753 769 10.1007/s00109-002-0384-9 (Pubitemid 35478124)
26. Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes. Matikainen N, Manttari S, Schweizer A, Ulvestad A, Mills D, Dunning BE, Foley JE, Taskinen MRMatikainen N, Manttari S, Schweizer A, Ulvestad A, Mills D, Dunning BE, Foley JE, Taskinen MR, Diabetologia 2006 49 2049 2057 10.1007/s00125-006-0340-2 16816950 (Pubitemid 44168471)
27. Serum levels of advanced glycation end products (AGEs) are independently correlated with circulating levels of dipeptidyl peptidase-4 (DPP-4) in humans. Tahara N, Yamagishi SI, Takeuchi M, Tahara A, Kaifu K, Ueda S, Okuda S, Imaizumi TTahara N, Yamagishi SI, Takeuchi M, Tahara A, Kaifu K, Ueda S, Okuda S, Imaizumi T, Clin Biochem 2012 in press 10.1016/j.clinbiochem.2012.11.023
28. A common single nucleotide polymorphism alters the synthesis and secretion of neuropeptide Y. Mitchell GC, Wang Q, Ramamoorthy P, Whim MDMitchell GC, Wang Q, Ramamoorthy P, Whim MD, J Neurosci 2008 28 14428 14434 10.1523/JNEUROSCI.0343-08.2008 19118176
29. Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Karvonen MK, Pesonen U, Koulu M, Niskanen L, Laakso M, Rissanen A, Dekker JM, Hart LM, Valve R, Uusitupa MIKarvonen MK, Pesonen U, Koulu M, Niskanen L, Laakso M, Rissanen A, Dekker JM, Hart LM, Valve R, Uusitupa MI, Nat Med 1998 4 1434 1437 10.1038/4027 9846584 (Pubitemid 28553469)
30. 5-Aza-2′-deoxycytidine induced growth inhibition of leukemia cells through modulating endogenous cholesterol biosynthesis. Zhang F, Dai X, Wang YZhang F, Dai X, Wang Y, Mol Cell Proteomics 2012 11 111 22493179
31. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, Ji H, Potash JB, Sabunciyan S, Feinberg APIrizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, Ji H, Potash JB, Sabunciyan S, Feinberg AP, Nat Genet 2009 41 178 186 10.1038/ng.298 19151715
32. An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Rakyan VK, Down TA, Thorne NP, Flicek P, Kulesha E, Graf S, Tomazou EM, Backdahl L, Johnson N, Herberth M, Howe KL, Jackson DK, Miretti MM, Fiegler H, Marioni JC, Birney E, Hubbard TJ, Carter NP, Tavare S, Beck SRakyan VK, Down TA, Thorne NP, Flicek P, Kulesha E, Graf S, Tomazou EM, Backdahl L, Johnson N, Herberth M, Genome Res 2008 18 1518 1529 10.1101/gr.077479.108 18577705
33. Epigenome-wide association studies for common human diseases. Rakyan VK, Down TA, Balding DJ, Beck SRakyan VK, Down TA, Balding DJ, Beck S, Nat Rev Genet 2011 12 529 541 10.1038/nrg3000 21747404
34. Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue. O'Rourke RW, Metcalf MD, White AE, Madala A, Winters BR, Maizlin II, Jobe BA, Roberts CT Jr, Slifka MK, Marks DLO'Rourke RW, Metcalf MD, White AE, Madala A, Winters BR, Maizlin II, Jobe BA, Roberts CT Jr, Slifka MK, Marks DL, Int J Obes (Lond) 2009 33 978 990 10.1038/ijo.2009.133
35. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, Tsui H, Wu P, Davidson MG, Alonso MN, Leong HX, Glassford A, Caimol M, Kenkel JA, Tedder TF, McLaughlin T, Miklos DB, Dosch HM, Winer DA, Engleman EG, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, Tsui H, Wu P, Davidson MG, Alonso MN, Leong HX, Glassford A, Caimol M, Kenkel JA, Nat Med 2011 17 610 617 10.1038/nm.2353 21499269
36. Normalization of obesity-associated insulin resistance through immunotherapy. Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, Dorfman R, Wang Y, Zielenski J, Mastronardi F, Maezawa Y, Drucker DJ, Engleman E, Winer D, Dosch HMWiner S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, Dorfman R, Wang Y, Zielenski J, Mastronardi F, Maezawa Y, Drucker DJ, Engleman E, Winer D, Dosch HM, Nat Med 2009 15 921 929 10.1038/nm.2001 19633657